Skip to main content

Table 2 Assessment schedule

From: An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial

Variables

Timing (days)

1

2

3

4

5

6

7

8

9

10

11

21+/−2

M3

RDT Bubo/sputum

X

            

PCR Bubo/sputum

X

            

Bubo/sputum culture

X

            

Plague serology

X

         

X

X

X*

Malaria Ag

X

            
  1. *Only subjects with positive serology on the 21st day will participate in this follow-up
Back to article page

Trials

ISSN: 1745-6215